Ranibizumab pretreatment in diabetic vitrectomy: a pilot randomised controlled trial (the RaDiVit study)

Purpose Our aim was to evaluate the impact of intravitreal ranibizumab pretreatment on the outcome of vitrectomy surgery for advanced proliferative diabetic retinopathy. The objective was to determine the feasibility of a subsequent definitive trial and estimate the effect size and variability of th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Eye (London) 2017-09, Vol.31 (9), p.1253-1258
Hauptverfasser:	Comyn, O, Wickham, L, Charteris, D G, Sullivan, P M, Ezra, E, Gregor, Z, Aylward, G W, da Cruz, L, Fabinyi, D, Peto, T, Restori, M, Xing, W, Bunce, C, Hykin, P G, Bainbridge, J W
Format:	Artikel
Sprache:	eng
Schlagworte:	692/308/409 Acuity Angiogenesis Inhibitors - therapeutic use Clinical Study Diabetes Diabetes mellitus Diabetic retinopathy Diabetic Retinopathy - physiopathology Diabetic Retinopathy - surgery Double-Blind Method Endotamponade Female Fluorescein Angiography Hemorrhage Humans Immunotherapy Intravitreal Injections Laboratory Medicine Laser Coagulation Male Medicine Medicine & Public Health Middle Aged Monoclonal antibodies Ophthalmology Pharmaceutical Sciences/Technology Pilot Projects Ranibizumab - therapeutic use Retina Retinal Detachment - physiopathology Retinal Detachment - surgery Retinopathy Surgery Surgical Oncology Treatment Outcome Vascular Endothelial Growth Factor A - antagonists & inhibitors Visual Acuity - physiology Vitrectomy Vitreous Hemorrhage - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!